News & Events

Hear about our latest news, events and funding opportunities.


Tuesday 07 August 2018
Simon MacKenzie, SMS-IC

Boston, Massachusetts has a reputation as one of the top life sciences clusters in the world, due in large part to its unique cooperation between industry, government and academia. It has more biotech research and development employees than anywhere else in the USA and is home to thousands of well-funded life sciences companies who are driving innovation.

Ovarian Cancer - Exemplar Project Case Study

Tuesday 07 August 2018
Professor Charlie Gourley, Professor in Medical Oncology at the Edinburgh Cancer Research Centre.

Ovarian cancer is often known as the ‘silent killer’, because its symptoms can be mistaken for other less harmful conditions, or simply put down to changes in the body due to ageing. This means around 7 in 10 cases are diagnosed at a late stage, by which time the cancer has often spread or is difficult to cure.

Case study: Kirsty Woodall

Tuesday 07 August 2018

Kirsty carried out a work placement at Stratified Medicine Scotland Innovation Centre (SMS-IC) as part of her MSc in Stratified Medicine and Pharmacological Innovation, which she studied at the University of Glasgow.

The one-year course is being developed in conjunction with SMS-IC and aims to create a highly trained workforce that will help address a shortage of skills in stratified medicine, which is a key growth sector in Scotland’s economy. Places on the course are fully funded by the Scottish Funding Council.

MSP Johann Lamont visit to Stratified Medicine Scotland Innovation Centre

Monday 18 June 2018
SMS-IC Admin

Today (Monday 18 June) MSP Johann Lamont visited the Stratified Medicine Scotland Innovation Centre (SMS-IC) in Glasgow, to see first-hand how it is bringing together industry innovators, clinicians and world-class researchers together to work on precision medicine. 

Precision medicine ensures drugs are specifically targeted to a person’s genetic makeup rather than a “one size fits all” approach.  This helps get the right treatment to the right person at the right time, improving outcomes for patients and slashing the costs of ineffective treatments, saving lives and scarce NHS resources.

Rheumatoid Arthritis - Exemplar Project Case Study

Monday 18 June 2018
Professor Iain McInnes, Professor in Experimental Medicine at the University of Glasgow

Rheumatoid Arthritis currently affects around 35,000 people in Scotland. It causes joint pain, swelling and stiffness, affecting a patient’s mobility and interfering with their quality of life and ability to work. Patients may need long-term treatment to control their symptoms and reduce joint damage.

Despite the fact that treatment options have improved in the last 20 years, the UK National Audit Office estimates that rheumatoid arthritis costs the NHS around £560 million every year. A significant part of this cost is down to failed treatments.

Professor Iain McInnes of the University of Glasgow explains how a precision medicine project being carried out by Stratified Medicine Scotland Innovation Centre could help both patients and the NHS.

International NASH Day blog

Tuesday 12 June 2018
Prof Jonathan Fallowfield

Today (12th June 2018) is the first International NASH Day – a day to help raise awareness of this silent epidemic which currently has no approved treatment. We’re working on a project which we hope will change this –please read on for more information


£1.7M of Innovate UK funding will help tackle silent killer that could affect one in four Scots

Friday 09 February 2018

Funding will help develop new treatments for the commonest cause of chronic liver disease

SMS-IC attending BIO-EUROPE SPRING Partnering Conference

Friday 02 February 2018
Diane Harbison

Stratified Medicine Scotland understands that in order to find new and exciting opportunities, there's nothing like face-to-face meetings.

Glasgow Scientists Set to Lead New Era in Pancreatic Cancer Treatment

Friday 24 March 2017

Scotland’s investments create a launch-pad for ambitious large-scale programmes in Precision Medicine.

Investing in research

Wednesday 26 October 2016

A new collaboration in genomic medicine sees Scotland join AstraZeneca’s global genomics initiative – further demonstrating Scotland’s ability to attract major industry projects.